Low vancomycin MICs and fecal densities reduce the sensitivity of screening methods for vancomycin resistance in enterococci

Journal of Clinical Microbiology

Volumn 52, Issue 8, 2014, Pages 2829-2833

  Wijesuriya, Thamara M ^a   Perry, Peta ^a   Pryce, Todd ^a   Boehm, John ^a   Kay, Ian ^a   Flexman, James ^a   Coombs, Geoffrey W ^a,b   Ingram, Paul R ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; VANCOMYCIN; ANTIINFECTIVE AGENT; CULTURE MEDIUM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CULTURE MEDIUM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; EPSILOMETER TEST; FECES CULTURE; GENOTYPE; INTERMETHOD COMPARISON; LIQUID CULTURE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VANCOMYCIN RESISTANT ENTEROCOCCUS; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; ENTEROCOCCUS; EVALUATION STUDY; FECES; GRAM POSITIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; CULTURE MEDIA; ENTEROCOCCUS; FECES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84905270770     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00021-14     Document Type: Article

References (34)

1. Christiansen KJ, Tibbett PA, Beresford W, Pearman JW, Lee RC, Coombs GW, Kay ID, O'Brien FG, Palladino S, Douglas CR, Montgomery PD, Orrell T, Peterson AM, Kosaras FP, Flexman JP, Heath CH, McCullough CA. 2004. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect. Control Hosp. Epidemiol. 25:384-390. http://dx.doi.org/10.1086/502410. (Pubitemid 38621084)
2. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. 2007. Management of multi-drug-resistant organisms in health care settings, 2006. Am. J. Infect. Control 35:S165-S193. http://dx.doi.org/10.1016/j.ajic.2007.10.006. (Pubitemid 350225593)
3. Klare I, Fleige C, Geringer U, Witte W, Werner G. 2012. Performance of three chromogenic VRE screening agars, two Etest® vancomycin protocols, and different microdilution methods in detecting vanB genotype Enterococcus faecium with varying vancomycin MICs. Diagn. Microbiol. Infect. Dis. 74:171-176. http://dx.doi.org/10.1016/j.diagmicrobio.2012.06.020.
4. Pendle S, Jelfs P, Olma T, Su Y, Gilroy N, Gilbert GL. 2008. Difficulties in detection and identification of Enterococcus faecium with low-level inducible resistance to vancomycin, during a hospital outbreak. Clin. Microbiol. Infect. 14:853-857. http://dx.doi.org/10.1111/j.1469-0691.2008.02052.x.
5. Leclercq R, Derlot E, Duval J, Courvalin P. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161. http://dx.doi.org/10.1056/NEJM198807213190307.
6. Uttley AH, Collins CH, Naidoo J, George RC. 1988. Vancomycin-resistant enterococci. Lancet i:57-58. (Pubitemid 18017235)
7. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, Eisner W, Warren S, Kreiswirth B. 1993. Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76-79. http://dx.doi.org/10.1016/0140-6736(93)91285-T. (Pubitemid 23192423)
8. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SKNational Healthcare Safety Network Team, Participating National Healthcare Safety Network Facilities. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011. http://dx.doi.org/10.1086/591861.
9. Johnson PD, Ballard SA, Grabsch EA, Stinear TP, Seemann T, Young HL, Grayson ML, Howden BP. 2010. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. J. Infect. Dis. 202:1278-1286. http://dx.doi.org/10. 1086/656319.
10. Christiansen KJ, Turnidge JD, Bell JM, George NM, Pearson JC, Australian Group on Antimicrobial Resistance. 2007. Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial Resistance. Commun. Dis. Intell. Q. Rep. 31:392-397. http://www.health.gov.au/internet/main/publishing.nsf/Content/ cda-cdi3104-pdf-cnt.htm/$FILE/cdi3104f.pdf.
11. Bell J, Turnidge J, Coombs G, O'Brien F. 1998. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun. Dis. Intell. 22:249-252.
12. Coombs GW, Pearson JC, Daley DA, Le T, Robinson OJ, Gottlieb T, Howden BP, Johnson PD, Bennett CM, Stinear TP, Turnidge JD, Australian Group on Antimicrobial Resistance. 2014. Molecular epidemiology of enterococcal bacteremia in Australia. J. Clin. Microbiol. 52:897-905. http://dx.doi.org/10. 1128/JCM.03286-13.
13. CLSI. 2012. Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement. M100-S22. CLSI, Wayne, PA.
14. Mendes RE, Woosley LN, Farrell DJ, Sader HS, Jones RN. 2012. Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010. Antimicrob. Agents Chemother. 56:1639-1642. http://dx.doi.org/10.1128/AAC.06067-11.
15. Jones RN, Sader HS, Flamm RK. 2013. Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011). Diagn. Microbiol. Infect. Dis. 75:304-307. http://dx.doi.org/10.1016/j. diagmicrobio.2012.11.024.
16. Soderblom T, Aspevall O, Erntell M, Hedin G, Heimer D, Hokeberg I, Kidd-Ljunggren K, Melhus A, Olsson-Liljequist B, Sjogren I, Smedjegard J, Struwe J, Sylvan S, Tegmark-Wisell K, Thore M. 2010. Alarming spread of vancomycin resistant enterococci in Sweden since 2007. Euro Surveill. 15:pii:19620. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19620.
17. Lopez M, Cercenado E, Tenorio C, Ruiz-Larrea F, Torres C. 2012. Diversity of clones and genotypes among vancomycin-resistant clinical Enterococcus isolates recovered in a Spanish hospital. Microb. Drug Resist. 18:484-491. http://dx.doi.org/10.1089/mdr.2011.0203.
18. Werner G, Klare I, Fleige C, Geringer U, Witte W, Just HM, Ziegler R. 2012. Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU. Antimicrob. Resist. Infect. Control 1:21. http://dx.doi.org/10.1186/2047-2994-1-21.
19. McCracken M, Wong A, Mitchell R, Gravel D, Conly J, Embil J, Johnston L, Matlow A, Ormiston D, Simor AE, Smith S, Du T, Hizon R, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. 2013. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009. J. Antimicrob. Chemother. 68:1505-1509. http://dx.doi.org/10.1093/jac/dkt054.
20. Palladino S, Kay ID, Costa AM, Lambert EJ, Flexman JP. 2003. Real-time PCR for the rapid detection of vanA and vanB genes. Diagn. Microbiol. Infect. Dis. 45:81-84. http://dx.doi.org/10.1016/S0732-8893(02)00505-9. (Pubitemid 36165035)
21. Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, Van Embden JD, Willems RJ. 2002. Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol. 40:1963-1971. http://dx.doi.org/10.1128/JCM.40.6.1963-1971. 2002. (Pubitemid 34596369)
22. Palladino S, Kay ID, Flexman JP, Boehm I, Costa AM, Lambert EJ, Christiansen KJ. 2003. Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J. Clin. Microbiol. 41:2483-2486. http://dx.doi.org/10.1128/JCM.41.6.2483-2486. 2003. (Pubitemid 36712456)
23. Kuch A, Stefaniuk E, Ozorowski T, Hryniewicz W. 2009. New selective and differential chromogenic agar medium, chromID VRE, for screening vancomycin-resistant Enterococcus species. J. Microbiol. Methods 77:124-126. http://dx.doi.org/10.1016/j.mimet.2009.01.004.
24. D'Agata EM, Gautam S, Green WK, Tang YW. 2002. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin. Infect. Dis. 34:167-172. http://dx.doi.org/10.1086/338234. (Pubitemid 34028347)
25. Hegstad K, Giske CG, Haldorsen B, Matuschek E, Schonning K, Leegaard TM, Kahlmeter G, Sundsfjord A, on behalf of the NordicAST VRE Detection Study Group. 2014. Performance of the EUCAST disk diffusion method, CLSI agar screen and VITEK 2 automated antimicrobial susceptibility testing system in detection of clinical isolates of enterococci with low and medium level VanB-type vancomycin resistance: a multicenter study. J. Clin. Microbiol. 52:1582-1589. http://dx.doi.org/10.1128/JCM.03544-13.
26. Nelson RR. 1998. Selective isolation of vancomycin-resistant enterococci. J. Hosp. Infect. 39:13-18. http://dx.doi.org/10.1016/S0195-6701(98)90238-9. (Pubitemid 28242979)
27. Grabsch EA, Ghaly-Derias S, Gao W, Howden BP. 2008. Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs. J. Clin. Microbiol. 46:4034-4036. http://dx.doi.org/10.1128/ JCM.00944-08.
28. Grabsch EA, Chua K, Xie S, Byrne J, Ballard SA, Ward PB, Grayson ML. 2008. Improved detection of vanB2-containing Enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J. Clin. Microbiol. 46:1961-1964. http://dx.doi.org/10.1128/JCM.01778-07. (Pubitemid 351831827)
29. Nordmann P, Poirel L. 2013. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J. Antimicrob. Chemother. 68:487-489. http://dx.doi.org/10.1093/jac/dks426.
30. Yamada K, Inuzuka K, Tatsumi N, Sanzen I, Ohkura T, Okamoto A, Hasegawa T, Ohta M. 2010. Evaluation of selection media for the detection of borderline MRSA. J. Infect. Chemother. 16:19-24. http://dx.doi.org/10.1007/s10156-009-0009- 0.
31. Drews SJ, Johnson G, Gharabaghi F, Roscoe M, Matlow A, Tellier R, Richardson SE. 2006. A 24-hour screening protocol for identification of vancomycin-resistant Enterococcus faecium. J. Clin. Microbiol. 44:1578-1580. http://dx.doi.org/10.1128/JCM.44.4.1578-1580.2006.
32. Peltroche-Llacsahuanga H, Top Weber-Heynemann JJ, Lutticken R, Haase G. 2009. Comparison of two chromogenic media for selective isolation of vancomycin-resistant enterococci from stool specimens. J. Clin. Microbiol. 47:4113-4116. http://dx.doi.org/10.1128/JCM.00882-09.
33. Ledeboer NA, Das K, Eveland M, Roger-Dalbert C, Mailler S, Chatellier S, Dunne WM. 2007. Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates. J. Clin. Microbiol. 45:1556-1560. http://dx.doi.org/10.1128/ JCM.02116-06. (Pubitemid 46762413)
34. Graham M, Ballard SA, Grabsch EA, Johnson PD, Grayson ML. 2008. High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob. Agents Chemother. 52:1195-1197. http://dx.doi.org/10.1128/AAC.00531- 07. (Pubitemid 351358417)